FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Madsen

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

X Ray Computed Tomography

Anatomy

Pelvis

Co-author Network

Publications

TOP 3
Kevin S Berbaum; Robert T Caldwell; George Y El-Khoury; Mark Madsen; Kenjirou Ohashi; Kevin M Schartz; Edmund A Franken
Satisfaction of search for subtle skeletal fractures may not be induced by more serious skeletal injury.
Yusuf Menda; M Sue O'Dorisio; Simon Kao; Geetika Khanna; Stacy Michael; Mary Connolly; John Babich; Thomas O'Dorisio; David Bushnell; Mark Madsen
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.
Kevin S Berbaum; Georges Y El-Khoury; Kenjirou Ohashi; Kevin M Schartz; Robert T Caldwell; Mark Madsen; Edmund A Franken
Satisfaction of search in multitrauma patients: severity of detected fractures.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Madsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kevin S Berbaum; Robert T Caldwell; George Y El-Khoury; Mark Madsen; Kenjirou Ohashi; Kevin M Schartz; Edmund A Franken
Satisfaction of search for subtle skeletal fractures may not be induced by more serious skeletal injury.
Journal of the American College of Radiology : JACR 2012;9(5):344-51.
2010: Yusuf Menda; M Sue O'Dorisio; Simon Kao; Geetika Khanna; Stacy Michael; Mary Connolly; John Babich; Thomas O'Dorisio; David Bushnell; Mark Madsen
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(10):1524-31.
2007: Kevin S Berbaum; Georges Y El-Khoury; Kenjirou Ohashi; Kevin M Schartz; Robert T Caldwell; Mark Madsen; Edmund A Franken
Satisfaction of search in multitrauma patients: severity of detected fractures.
Academic radiology 2007;14(6):711-22.
2004: David Bushnell; Yusuf Menda; Thomas M O'Dorisio; Mark Madsen; Sara Miller; Thomas Carlisle; Shayne Squires; Daniel Kahn; Wayne Walkner; Mary Connolly; M Sue O'Dorisio; Mark Karwal; James Ponto; Hakim Bouterfa
Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):35-41.
2003: David Bushnell; Yusuf Menda; Mark Madsen; Thomas M O'Dorisio; Thomas Carlisle; Pamela Zehr; Laura Ponto; Mark Karwal; Stan Parker; James Ponto; Mary Connolly; Hakim Bouterfa
Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):581-8.
2002: Malik E Juweid; Yusuf Menda; M Sue O'Dorisio; David Bushnell; M Blake; Mark Madsen; J Johnson; Michael M Graham
111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Nuclear medicine communications 2002;23(10):983-9.